
Vetoquinol Investor Relations Material
Latest events

Q1 2025 TU
24 Apr, 2025

H2 2024
20 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vetoquinol SA
Access all reports
Vetoquinol SA is a French veterinary pharmaceutical company that focuses on the development, production, and marketing of veterinary drugs and non-medicinal products. The company provides a diverse range of products aimed at improving the health of companion animals, such as dogs and cats, as well as livestock including cattle and pigs. Vetoquinol's product offerings cover various therapy areas like pain management, mobility, inflammation, dermatology, udder health, anti-parasite solutions, and cardiology among others. The company is headquartered in Lure, France, and its shares are listed on the Euronext Paris.
Key slides for Vetoquinol SA


H1 2024
Vetoquinol SA


H1 2024
Vetoquinol SA
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
VETO
Country
🇫🇷 France